KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $354,666 | +65.5% | 8,306 | +86.1% | 0.00% | +100.0% |
| Q4 2022 | $214,265 | +1847.9% | 4,462 | +1412.5% | 0.00% | – |
| Q3 2022 | $11,000 | -98.4% | 295 | -98.8% | 0.00% | -100.0% |
| Q2 2022 | $673,000 | +5076.9% | 24,346 | +11276.6% | 0.00% | – |
| Q4 2021 | $13,000 | -93.4% | 214 | -95.7% | 0.00% | -100.0% |
| Q3 2021 | $197,000 | +3183.3% | 4,972 | +4872.0% | 0.00% | – |
| Q1 2021 | $6,000 | -57.1% | 100 | -50.0% | 0.00% | – |
| Q4 2020 | $14,000 | -60.0% | 200 | -77.9% | 0.00% | -100.0% |
| Q3 2020 | $35,000 | +2.9% | 907 | +1.0% | 0.00% | 0.0% |
| Q2 2020 | $34,000 | – | 898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |